Global Oral Antiviral Medications for COVID-19 Market Growth 2025-2031

The global Oral Antiviral Medications for COVID-19 market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

Lagevrio and Paxlovid have both been found to be effective in treating mild to moderate COVID-19 in adults aged 18 years of age and older, who do not require supplemental oxygen, and who are at increased risk of progression to hospitalisation. The advantage of these oral medications is that many people will be able to receive treatment for COVID-19 in their own homes without the need to travel to hospital for treatment as an inpatient.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LP Information, Inc. (LPI) ' newest research report, the “Oral Antiviral Medications for COVID-19 Industry Forecast” looks at past sales and reviews total world Oral Antiviral Medications for COVID-19 sales in 2024, providing a comprehensive analysis by region and market sector of projected Oral Antiviral Medications for COVID-19 sales for 2025 through 2031. With Oral Antiviral Medications for COVID-19 sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oral Antiviral Medications for COVID-19 industry.

This Insight Report provides a comprehensive analysis of the global Oral Antiviral Medications for COVID-19 landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oral Antiviral Medications for COVID-19 portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oral Antiviral Medications for COVID-19 market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oral Antiviral Medications for COVID-19 and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oral Antiviral Medications for COVID-19.

This report presents a comprehensive overview, market shares, and growth opportunities of Oral Antiviral Medications for COVID-19 market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Tablet
Capsule

Segmentation by Application:
Hospital
Clinics

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Pfizer
Merck
Shionogi
Frontier Biotechnologies
Simcere Pharmaceutical
Guangdong Zhongsheng

Key Questions Addressed in this Report

What is the 10-year outlook for the global Oral Antiviral Medications for COVID-19 market?

What factors are driving Oral Antiviral Medications for COVID-19 market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Oral Antiviral Medications for COVID-19 market opportunities vary by end market size?

How does Oral Antiviral Medications for COVID-19 break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.